# An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma

> **NCT01706198** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 4233 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone furoate + vilanterol
- **DRUG:** inhaled corticosteroid with or without a long acting beta2-agonist

## Key facts

- **NCT ID:** NCT01706198
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-01
- **Primary completion:** 2016-12-01
- **Final completion:** 2016-12-16
- **Target enrollment:** 4233 (ACTUAL)
- **Last updated:** 2019-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706198, "An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01706198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*